An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients

Joseph Patrick McEvoy, Gunilla Movin-Osswald, Gunilla Uppfeldt, Tracy Williams, Susan Dutcher, Joy Apperson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Following a 4-7 day drug-free washout period, eight male inpatients took an extended-release (ER) formulation of raclopride. After the initial 8 mg dose on day 1 of the study, repeated plasma samples were collected over the ensuing 36 h. Subsequently, patients received raclopride 8 mg b.i.d. through day 7, 12 mg b.i.d. through day 14, and, if tolerated, 16 mg b.i.d. through day 21. On days 7, 14, and 21, repeated plasma samples were drawn over the 12 h following the morning dose. Relative to the previously studied immediate release form of raclopride, the ER formulation delayed and extended the absorption of raclopride, and produced lower maximum raclopride concentrations. Linear kinetics were preserved across the dose range studied. Two patients could not tolerate the highest raclopride dose because of extrapyramidal side effects.

Original languageEnglish (US)
Pages (from-to)371-374
Number of pages4
JournalPsychopharmacology
Volume112
Issue number2-3
DOIs
StatePublished - Sep 1 1993
Externally publishedYes

Fingerprint

Raclopride
Capsules
Psychiatry
Pharmacokinetics
Inpatients
Pharmaceutical Preparations

Keywords

  • Pharmacokinetics
  • Psychiatric patients
  • Raclopride
  • Tolerability

ASJC Scopus subject areas

  • Pharmacology

Cite this

An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients. / McEvoy, Joseph Patrick; Movin-Osswald, Gunilla; Uppfeldt, Gunilla; Williams, Tracy; Dutcher, Susan; Apperson, Joy.

In: Psychopharmacology, Vol. 112, No. 2-3, 01.09.1993, p. 371-374.

Research output: Contribution to journalArticle

McEvoy, Joseph Patrick ; Movin-Osswald, Gunilla ; Uppfeldt, Gunilla ; Williams, Tracy ; Dutcher, Susan ; Apperson, Joy. / An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients. In: Psychopharmacology. 1993 ; Vol. 112, No. 2-3. pp. 371-374.
@article{4be984406c784d6eb9953af0a6bacb1e,
title = "An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients",
abstract = "Following a 4-7 day drug-free washout period, eight male inpatients took an extended-release (ER) formulation of raclopride. After the initial 8 mg dose on day 1 of the study, repeated plasma samples were collected over the ensuing 36 h. Subsequently, patients received raclopride 8 mg b.i.d. through day 7, 12 mg b.i.d. through day 14, and, if tolerated, 16 mg b.i.d. through day 21. On days 7, 14, and 21, repeated plasma samples were drawn over the 12 h following the morning dose. Relative to the previously studied immediate release form of raclopride, the ER formulation delayed and extended the absorption of raclopride, and produced lower maximum raclopride concentrations. Linear kinetics were preserved across the dose range studied. Two patients could not tolerate the highest raclopride dose because of extrapyramidal side effects.",
keywords = "Pharmacokinetics, Psychiatric patients, Raclopride, Tolerability",
author = "McEvoy, {Joseph Patrick} and Gunilla Movin-Osswald and Gunilla Uppfeldt and Tracy Williams and Susan Dutcher and Joy Apperson",
year = "1993",
month = "9",
day = "1",
doi = "10.1007/BF02244935",
language = "English (US)",
volume = "112",
pages = "371--374",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2-3",

}

TY - JOUR

T1 - An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients

AU - McEvoy, Joseph Patrick

AU - Movin-Osswald, Gunilla

AU - Uppfeldt, Gunilla

AU - Williams, Tracy

AU - Dutcher, Susan

AU - Apperson, Joy

PY - 1993/9/1

Y1 - 1993/9/1

N2 - Following a 4-7 day drug-free washout period, eight male inpatients took an extended-release (ER) formulation of raclopride. After the initial 8 mg dose on day 1 of the study, repeated plasma samples were collected over the ensuing 36 h. Subsequently, patients received raclopride 8 mg b.i.d. through day 7, 12 mg b.i.d. through day 14, and, if tolerated, 16 mg b.i.d. through day 21. On days 7, 14, and 21, repeated plasma samples were drawn over the 12 h following the morning dose. Relative to the previously studied immediate release form of raclopride, the ER formulation delayed and extended the absorption of raclopride, and produced lower maximum raclopride concentrations. Linear kinetics were preserved across the dose range studied. Two patients could not tolerate the highest raclopride dose because of extrapyramidal side effects.

AB - Following a 4-7 day drug-free washout period, eight male inpatients took an extended-release (ER) formulation of raclopride. After the initial 8 mg dose on day 1 of the study, repeated plasma samples were collected over the ensuing 36 h. Subsequently, patients received raclopride 8 mg b.i.d. through day 7, 12 mg b.i.d. through day 14, and, if tolerated, 16 mg b.i.d. through day 21. On days 7, 14, and 21, repeated plasma samples were drawn over the 12 h following the morning dose. Relative to the previously studied immediate release form of raclopride, the ER formulation delayed and extended the absorption of raclopride, and produced lower maximum raclopride concentrations. Linear kinetics were preserved across the dose range studied. Two patients could not tolerate the highest raclopride dose because of extrapyramidal side effects.

KW - Pharmacokinetics

KW - Psychiatric patients

KW - Raclopride

KW - Tolerability

UR - http://www.scopus.com/inward/record.url?scp=0027220320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027220320&partnerID=8YFLogxK

U2 - 10.1007/BF02244935

DO - 10.1007/BF02244935

M3 - Article

C2 - 7871044

AN - SCOPUS:0027220320

VL - 112

SP - 371

EP - 374

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2-3

ER -